SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Expanding the Toolbox for Prevention
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
HPTN 069/ACTG 5305: Phase II Study of Maraviroc-Based Regimens for HIV PrEP in MSM
Roy Gulick
Weill Cornell Medical College, New York, NY, United States
PrEP Impact on T-Cell Activation and Explant Infection: HPTN 069/ACTG 5305 Substudy
Ian McGowan
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
Cabotegravir Long-Acting Injection Protects Macaques Against Intravenous Challenge
Chasity D. Andrews
Aaron Diamond AIDS Research Center, New York, NY, United States
ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV-Uninfected Men
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, United States
Chemoprophylaxis With Oral FTC/TAF Protects Macaques From Rectal SHIV Infection
Gerardo Garcia-Lerma
Centers for Disease Control and Prevention, Atlanta, GA, United States
MTN-017: Rectal Phase 2 Extended Safety and Acceptability Study of 1% Tenofovir Gel
Ross Cranston
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women
Jared M. Baeten
University of Washington, Seattle, WA, United States
Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women
Annalene Nel
International Partnership for Microbicides, Paarl, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
